Literature DB >> 22959907

Critical role of VEGF-C/VEGFR-3 signaling in innate and adaptive immune responses in experimental obliterative bronchiolitis.

Rainer Krebs1, Jussi M Tikkanen, Jussi O Ropponen, Michael Jeltsch, Janne J Jokinen, Seppo Ylä-Herttuala, Antti I Nykänen, Karl B Lemström.   

Abstract

Chronic inflammation, a hallmark of obliterative bronchiolitis, is known to induce lymphangiogenesis. We therefore studied the role of lymphangiogenic vascular endothelial growth factor C (VEGF-C), its receptor VEGFR-3, and lymphangiogenesis during development of experimental obliterative bronchiolitis [ie, obliterative airway disease (OAD)] in rat tracheal allografts. The functional importance of VEGF-C was investigated by adenovirus-mediated overexpression of VEGF-C (AdVEGF-C), and by inhibition of VEGF-C activity with VEGFR-3-Ig (AdVEGFR-3-Ig). Analyses included histology, immunohistochemistry, and real-time RT-PCR 10 and 30 days after transplantation. In the course of OAD development, lymphangiogenesis was induced in the airway wall during the alloimmune response, which was reversed by cyclosporine A in a dose-dependent fashion. VEGF-C overexpression in tracheal allografts induced epithelial activation, neutrophil chemotaxis, and a shift toward a Th17 adaptive immune response, followed by enhanced lymphangiogenesis and the development of OAD. In contrast, inhibition of VEGF-C activity with VEGFR-3-Ig inhibited lymphangiogenesis and angiogenesis and reduced infiltration of CD4(+) T cells and the development of OAD. Lymphangiogenesis was linked to T-cell responses during the development of OAD, and VEGF-C/VEGFR-3 signaling modulated innate and adaptive immune responses in the development of OAD in rat tracheal allografts. Our results thus suggest VEGFR-3-signaling as a novel strategy to regulate T-cell responses in the development of obliterative bronchiolitis after lung transplantation.
Copyright © 2012 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22959907     DOI: 10.1016/j.ajpath.2012.07.021

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  23 in total

1.  Therapeutic lymphangiogenesis ameliorates established acute lung allograft rejection.

Authors:  Ye Cui; Kaifeng Liu; Maria E Monzon-Medina; Robert F Padera; Hao Wang; Gautam George; Demet Toprak; Elie Abdelnour; Emmanuel D'Agostino; Hilary J Goldberg; Mark A Perrella; Rosanna Malbran Forteza; Ivan O Rosas; Gary Visner; Souheil El-Chemaly
Journal:  J Clin Invest       Date:  2015-10-20       Impact factor: 14.808

2.  Lymphatic drainage from bronchus-associated lymphoid tissue in tolerant lung allografts promotes peripheral tolerance.

Authors:  Wenjun Li; Jason M Gauthier; Alice Y Tong; Yuriko Terada; Ryuji Higashikubo; Christian C Frye; Margaret S Harrison; Kohei Hashimoto; Amit I Bery; Jon H Ritter; Ruben G Nava; Varun Puri; Brian W Wong; Kory J Lavine; Ankit Bharat; Alexander S Krupnick; Andrew E Gelman; Daniel Kreisel
Journal:  J Clin Invest       Date:  2020-12-01       Impact factor: 14.808

Review 3.  Lymphatic Vessels: The Next Frontier in Lung Transplant.

Authors:  Ye Cui; Kaifeng Liu; Anthony Mark Lamattina; Gary Visner; Souheil El-Chemaly
Journal:  Ann Am Thorac Soc       Date:  2017-09

Review 4.  Exploiting lymphatic vessels for immunomodulation: Rationale, opportunities, and challenges.

Authors:  Katharina Maisel; Maria Stella Sasso; Lambert Potin; Melody A Swartz
Journal:  Adv Drug Deliv Rev       Date:  2017-07-08       Impact factor: 15.470

5.  Lymphatic Proliferation Ameliorates Pulmonary Fibrosis after Lung Injury.

Authors:  Peter Baluk; Ram P Naikawadi; Shineui Kim; Felipe Rodriguez; Dongwon Choi; Young-Kwon Hong; Paul J Wolters; Donald M McDonald
Journal:  Am J Pathol       Date:  2020-10-08       Impact factor: 4.307

6.  Expression of vascular endothelial growth factor-C (VEGF-C) and its receptor (VEGFR-3) in the glial reaction elicited by human mesenchymal stem cell engraftment in the normal rat brain.

Authors:  Yoo-Jin Shin; Tae-Ryong Riew; Joo-Hee Park; Ha-Jin Pak; Mun-Yong Lee
Journal:  J Histochem Cytochem       Date:  2014-12-03       Impact factor: 2.479

7.  Pulmonary lymphangiectasia resulting from vascular endothelial growth factor-C overexpression during a critical period.

Authors:  Li-Chin Yao; Chiara Testini; Denis Tvorogov; Andrey Anisimov; Sara O Vargas; Peter Baluk; Bronislaw Pytowski; Lena Claesson-Welsh; Kari Alitalo; Donald M McDonald
Journal:  Circ Res       Date:  2014-01-15       Impact factor: 17.367

Review 8.  Lymphangiogenic factors, mechanisms, and applications.

Authors:  Wei Zheng; Aleksanteri Aspelund; Kari Alitalo
Journal:  J Clin Invest       Date:  2014-03-03       Impact factor: 14.808

9.  Donor-host Lymphatic Anastomosis After Murine Lung Transplantation.

Authors:  Hasina Outtz Reed; Liqing Wang; Mark L Kahn; Wayne W Hancock
Journal:  Transplantation       Date:  2020-03       Impact factor: 5.385

10.  Lung transplantation.

Authors:  Keith C Meyer
Journal:  F1000Prime Rep       Date:  2013-05-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.